Results 151 to 160 of about 123,729 (215)

Brachypodium HISTONE DEACETYLASE 19.1 promotes yield, flowering, and freezing tolerance at the expense of drought tolerance. [PDF]

BMC Plant Biol
Verrico B, Zhong J, Stavros C, Preston JC.   +3 more
europepmc   +1 more source

GV-001, An Oral Available Histone Deacetylase 6 Inhibitor for the Treatment of Autosomal Dominant Polycystic Kidney Disease. [PDF]

J Med Chem
Wu SS, Hung PY, Yeh TY, Lin PJ, Chern JW, Yu CW.   +5 more
europepmc   +1 more source

Therapeutic effect of histone deacetylase 6 inhibitor for a mouse model of phenylketonuria. [PDF]

Sci Rep
Choi JE, Park S, Song H, Hwang IT, Jung SC, Kim HS.   +5 more
europepmc   +1 more source

Transient histone deacetylase inhibition induces cellular memory of gene expression and 3D genome folding. [PDF]

Nat Genet
Paldi F, Szalay MF, Dufau S, Di Stefano M, Reboul H, Jost D, Bantignies F, Cavalli G.   +7 more
europepmc   +1 more source

NF-κB Is a Potential Therapeutic Target for Histone Deacetylase Inhibitor-Resistant Cutaneous T-Cell Lymphoma. [PDF]

Cancer Sci
Takahashi Y, Kitadate A, Iwama S, Kuroki W, Abe K, Yamada M, Ikeda S, Tagawa H, Wakui H, Hikida M, Takahashi N.   +10 more
europepmc   +1 more source

HISTONE DEACETYLASE-1 is required for epigenome stability in <i>Neurospora crassa</i>. [PDF]

Proc Natl Acad Sci U S A
Ebot-Ojong F, Ferraro AR, Yap RE, Kaddar F, Hull-Crew C, Scadden AW, Deaven AM, Klocko AD, Lewis ZA.   +8 more
europepmc   +1 more source

Design, Synthesis, and Biological Evaluation of Novel Triazine-Based Dual Histone Deacetylase/phosphatidylinositol 3-kinase Inhibitors for Breast Cancer Therapy. [PDF]

ChemMedChem
Luzietti L, Pires GS, Ryan A, Regidor C, Hiller M, Sarti D, Ní Chonghaile T, Pinheiro PSM, Varešlija D, Rodrigues DA.   +9 more
europepmc   +1 more source

Identification of Histone Deacetylase Inhibitor Targeting Type I Interferon and B Cell Abnormalities in Systemic Lupus Erythematosus. [PDF]

Arthritis Rheumatol
Hirayama T, Konaka H, Kato Y, Shibahara T, Nishizawa C, Tsujimoto K, Park J, Itotagawa E, Jo T, Nishide M, Nishida S, Shima Y, Narazaki M, Aoki W, Ishii KJ, Takamatsu H, Kumanogoh A.   +16 more
europepmc   +1 more source

Targeted Degradation of Histone Deacetylase 8 Using Proteolysis Targeting Chimeras Technology: A Promising Approach for Glioblastoma Treatment. [PDF]

Drug Des Devel Ther
Chotitumnavee J, Seemaung P, Settacomkul R, Sukprasert R, Itoh Y, Suzuki T, Srihirun S, Power C, Vivithanaporn P.   +8 more
europepmc   +1 more source

Role of Histone Deacetylase and Inhibitors in Cardiovascular Diseases. [PDF]

Cell Prolif
Zhang LY, Wang YY, Wen R, Zhang TN, Yang N.   +4 more
europepmc   +1 more source